摘要
We identified SARS-CoV-2 specific antigen epitopes by HLA-A2 binding affinity analysis and characterized their ability to activate T cells. As the pandemic continues, variations in SARS-CoV-2 virus strains have been found in many countries. In this study, we directly assess the immune response to SARS-CoV-2 epitope variants. We first predicted potential HLA-A*02:01-restricted CD8(+) T-cell epitopes of SARS-CoV-2. Using the T2 cell model, HLA-A*02:01-restricted T-cell epitopes were screened for their binding affinity and ability to activate T cells. Subsequently, we examined the identified epitope variations and analyzed their impact on immune response. Here, we identified specific HLA-A2-restricted T-cell epitopes in the spike protein of SARS-CoV-2. Seven epitope peptides were confirmed to bind with HLA-A*02:01 and potentially be presented by antigen-presenting cells to induce host immune responses. Tetramers containing these peptides could interact with specific CD8(+) T cells from convalescent COVID-19 patients, and one dominant epitope (n-Sp1) was defined. These epitopes could activate and generate epitope-specific T cells in vitro, and those activated T cells showed cytolytic activity toward target cells. Meanwhile, n-Sp1 epitope variant 5L>F significantly decreased the proportion of specific T-cell activation; n-Sp1 epitope 8L>V variant showed significantly reduced binding to HLA-A*02:01 and decreased proportion of n-Sp1-specific CD8(+) T cell, which potentially contributes to the immune escape of SARS-CoV-2. Our data indicate that the variation of a dominant epitope will cause the deficiency of HLA-A*02:01 binding and T-cell activation, which subsequently requires the formation of a new CD8(+) T-cell immune response in COVID-19 patients.
学科与关键词
- Identification of HLA-A2 restricted CD8+ T cell epitopes in SARS-CoV-2 structural proteinsDeng, Jieping; Pan, Junping; Qiu, Minghui; Mao, Lipeng; Wang, Zhigang; Zhu, Guodong; Gao, Lijuan; Su, Jun; Hu, Yutian; Luo, Oscar Junhong; Chen, Guobing*; Wang, Pengcheng*Journal of Leukocyte Biology, 2021, 110(6): 1171-1180.被引 9
- SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune responseXiao, Chanchan; Mao, Lipeng; Wang, Zhigang; Gao, Lijuan; Zhu, Guodong; Su, Jun; Chen, Xiongfei; Yuan, Jun; Hu, Yutian; Yin, Zhinan; Xie, Jun; Ji, Weiqing; Niu, Haitao; Gao, Feng; Luo, Oscar Junhong; Xiao, Lianbo*; Wang, Pengcheng*; Chen, Guobing*iScience, 2022, 25(3): 103934.被引 7
- SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivityMotozono, Chihiro; Toyoda, Mako; Zahradnik, Jiri; Saito, Akatsuki; Nasser, Hesham; Tan, Toong Seng; Ngare, Isaac; Kimura, Izumi; Uriu, Keiya; Kosugi, Yusuke; Yue, Yuan; Shimizu, Ryo; Ito, Jumpei; Torii, Shiho; Yonekawa, Akiko; Shimono, Nobuyuki; Nagasaki, Yoji; Minami, Rumi; Toya, Takashi; Sekiya, Noritaka; Fukuhara, Takasuke; Matsuura, Yoshiharu; Schreiber, Gideon; Ikeda, Terumasa*; Nakagawa, So*; Ueno, Takamasa*; Sato, Kei*Cell Host and Microbe, 2021, 29(7): 1124-+.被引 362
